Thrombocytopenia, anasarca, and severe inflammation
- PMID: 35794839
- PMCID: PMC9555220
- DOI: 10.1002/ajh.26651
Thrombocytopenia, anasarca, and severe inflammation
Conflict of interest statement
The authors have written permission from the patient to submit this manuscript for publication.In addition, the authors do not have any conflict of interest to disclose and did not receive any funding for publishing this manuscript.
Figures






References
-
- Nishimura Y, Fajgenbaum DC, Pierson SK, et al. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease. American Journal of Hematology. 2021;96(10):1241–1252. - PMC - PubMed
-
- Iwaki N, Fajgenbaum DC, Nabel CS, et al. Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. American Journal of Hematology. 2016;91(2):220–226. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources